Correction: High-sensitivity SpectroChip-integrated LFIA platform for rapid point-of-care quantification of

Cheng-Hao Ko1, Wei-Yi Kong1

  • 1Graduate Institute of Automation and Control (GIAC), National Taiwan University of Science and Technology (NTUST), Taipei, Taiwan. kevin.ko.ntust.2@gmail.com.

The Analyst
|December 9, 2025
PubMed
Summary

This correction clarifies a study on a high-sensitivity SpectroChip-integrated lateral flow immunoassay (LFIA) platform. The platform enables rapid point-of-care quantification of cardiovascular biomarkers for improved diagnostics.

Related Concept Videos